Background: Reducing blood product utilization after cardiac surgery has become a focus of perioperative care as studies have suggested improved outcomes. The relative impact of preoperative anemia versus packed red blood cells (PRBC) transfusion on outcomes remains poorly understood, however. In this study, we investigated the relative association between preoperative hematocrit (Hct) level and PRBC transfusion on postoperative outcomes after coronary artery bypass grafting (CABG) surgery.
Coronary artery bypass grafting (CABG) remains one of the most commonly performed surgical operations in the United States and worldwide. Cardiac surgical procedures are estimated to be responsible for nearly 20% of the annual blood transfusions in the United States, 1 and blood transfusion following CABG has been reported to occur in up to 60% of cases. 2, 3 Transfusion of allogenic blood products has been associated with significant adverse patient effects, including the occurrence of transfusion reactions, transfusion-related acute lung injury, immunosuppression and immunomodulation, infectious complications, and even reduced long-term survival. 2, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Although several series have investigated the independent effects of perioperative anemia and transfusion with packed red blood cells (PRBC), a fundamental question remains unanswered. Which factor (anemia or transfusion) contributes more to adverse cardiac surgical morbidity and mortality? Previous investigations have been frequently limited by examination of single-institution cohort analyses and heterogeneous surgical patient populations, and have failed to consider the nonlinear relationship between preoperative hematocrit (Hct) level and riskadjusted mortality and morbidity.
The purpose of the present study was to investigate the relative association between preoperative Hct versus PRBC transfusion on postoperative outcomes after CABG alone. We hypothesized that (1) a significant nonlinear relationship exists between preoperative Hct level and patient outcomes, as well as the need for PRBC transfusion, and (2) PRBC transfusion would have a stronger relative strength of association with postoperative mortality and morbidity compared with preoperative Hct level alone.
METHODS
The Virginia Cardiac Services Quality Initiative (VCSQI) consists of 19 cardiac surgical centers within Virginia and North Carolina. VCSQI centers perform approximately 99% of Virginia's cardiac operations, contributing patient data to the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database. This study was exempt from formal Institutional Review Board review at each participating hospital, owing to the secondary analysis of the VCSQI's deidentified (ie, absence of Health Insurance Portability and Accountability Act patient identifiers) data registry and because the data were collected for quality analysis and purposes other than research.
Patients and Data Acquisition
Deidentified patient data were extracted from the VCSQI data registry for the study period January 1, 2007, to December 31, 2017. The records included patients undergoing primary (ie, no previous sternotomy) isolated CABG operations (STS procedure type ''CAB Alone''). Patients who had missing preoperative Hct data or had undergone a concomitant valve procedure or other cardiac surgery were excluded. All CABG surgeries involved standard open surgical approaches to myocardial surgical revascularization with and without the use of cardiopulmonary bypass support. Patients' preoperative risk was assessed based on the presence of comorbidities, operative status, and individual calculated STS predicted risk score.
The primary outcomes of interest included risk-adjusted association between preoperative Hct level versus PRBC transfusion and the probability of operative mortality and measures of major morbidity, including likelihood of PRBC transfusion, renal failure, or stroke. PRBC transfusion was defined as either intraoperative or postoperative, both of which were correlated with postoperative complications. Standard STS clinical definitions were used for all analyzed variables. 16 
Statistical Analysis
For descriptive statistics, categorical variables are expressed as group percentages, and continuous variables are expressed as either mean AE standard deviation or median (interquartile range [IQR]), depending on overall variable distribution. Generalized linear mixed regression models were used to estimate the relationships between baseline preoperative Hct level and PRBC transfusion with the likelihood of postoperative mortality and morbidity, adjusted for baseline patient risk. Preoperative Hct values <17% or >54% were excluded, and the remaining values were modeled as a continuous function. Hct values were centered at their mean, 38.855%, to facilitate the convergence of the statistical models. The predicted associations between preoperative Hct level or PRBC transfusion and outcomes were adjusted for the confounding effects of preoperative patient risk profile (STS predicted risk scores) and year through the inclusion of these variables as model covariates. STS predicted risk scores were logit-transformed, which put them on the natural scale for inclusion as predictors in a logistic model. Hospital was included in the model as a random effect to account for clustering at the hospital level. 
RESULTS

Patient Characteristics and Operative Features for CABG Surgery
A total of 33,411 patients underwent primary, isolated CABG surgery. Table 1 presents descriptive statistics and frequencies of patient preoperative and operative characteristics. The median patient age was 65 years (IQR, 57-72 years), and females comprised 26% of the cohort. The mean STS predicted risk of mortality was 1.8 AE 3.1%. The most prevalent comorbid disease states included hypertension, dyslipidemia, diabetes, and cerebrovascular disease. The majority of patients presented without symptoms of heart failure. The median ejection fraction was 55% (IQR, 45%-60%). The majority of patients presented with 3-vessel coronary artery disease, and significant left main coronary artery disease was present in one-third of patients. The median preoperative Hct value was 39% (IQR, 36%-42%) for the study population. Figure 1 displays the distribution of preoperative Hct levels for the study population.
The majority of the CABG operations were performed in either an elective (35%) or urgent (61%) setting, with few done on emergent basis. CABG was performed with cardiopulmonary bypass support in 91% of cases. Off-pump CABG was performed in 8% of operations, and a combination of bypass support was provided in 1% of patients. The median cardiopulmonary bypass time was 92 minutes (IQR, 72-115 minutes), and the median aortic cross-clamp time was 67 minutes (IQR, 51-85 minutes). Left internal mammary artery conduits were used in 95% of cases; bilateral internal mammary artery conduits, in 3% of cases. The median lowest intraoperative Hct level was 25% (IQR, 21%-28%).
Postoperative Outcomes Following CABG Operations Table 2 displays the frequency of postoperative events and outcomes. Nearly one-third of patients received postoperative blood product transfusions; in those patients, the median number of PRBC units transfused was 2 (IQR, 1-4). Detailed intraoperative and postoperative transfusion rates are available in Table E1 . The most common postoperative complication was atrial fibrillation (20%). Prolonged mechanical ventilation was provided in 9% of patients. Renal failure occurred in 3% of patients; stroke, in 1.3%. Operative mortality was 2.0%. 
Adjusted Relationships Between Preoperative Hematocrit Level Versus PRBC Transfusion and Mortality and Morbidity
The relative strengths of association between riskadjusted outcomes and the effect of preoperative Hct level versus PRBC transfusion are displayed in Table 3 with the respective adjusted ORs, P values, and AUC values estimated from each regression model for the outcomes of operative mortality, postoperative renal failure, and postoperative stroke. Complete covariate information is available for each model in Tables E2-E4 . A strong association was observed between preoperative Hct and the likelihood of PRBC transfusion (OR, 0.82; 95% CI, 0.82-0.83; P <.001). After risk adjustment using the STS predicted risk of mortality, PRBC transfusion, but not Hct, demonstrated stronger associations with postoperative mortality (OR, 4.3; P < .0001), renal failure (OR, 6.3; P < .0001), and stroke (OR, 2.4; P < .0001). Although less strongly associated than PRBC transfusion, a 1-point increase in preoperative Hct was associated with a significantly decreased probability of mortality (OR, 0.97; P ¼ .00011) and renal failure (OR, 0.94; P < 2e-16). The PRBC models performed significantly better than the Hct models for mortality (AUC, 0.82693 vs 0.78886; P < .0001), renal failure (AUC, 0.86063 vs 0.82067; P <.0001), and stroke (0.72062 vs 0.69487; P ¼ .0013).
The adjusted associations between preoperative Hct and the probability of mortality, postoperative PRBC transfusion, and postoperative renal failure are shown in Figure 2 . Most importantly, these functions demonstrated that in an otherwise average patient preoperative anemia compared with an Hct level of 40% was associated with an almost 4-fold increase in the probability of PRBC transfusion, a 3-fold increase in renal failure, and a nearly doubled risk of mortality (Table 4) .
DISCUSSION
The present study reports on risk-adjusted relationships between postoperative mortality and morbidity as a function of preoperative Hct versus PRBC transfusion to better determine which factor confers a greater risk to patients undergoing CABG surgery. In this multi-institution analysis of more than 33,000 patient records, primary isolated CABG surgeries were evaluated to avoid the potential confounding effects on blood product requirements common during reoperations and combined procedures. As a result, the primary results demonstrate that although preoperative Hct and, more importantly, preoperative anemia are both associated with an increase in risk-adjusted mortality and morbidity, the effect of PRBC transfusion on patient outcomes is more profound. These results address an illdefined issue within cardiac surgical critical care to identify which factor is the greater culprit for worse outcomes following cardiac surgery. The risk-adjusted impact of preoperative Hct on mortality and morbidity in the present analysis is consistent with previous reports in patients undergoing cardiac surgery. Several studies have demonstrated a significant correlation between either preoperative or intraoperative anemia and adverse cardiac surgical outcomes. [17] [18] [19] [20] van Straten and colleagues 20 identified preoperative anemia as a significant risk factor for early and late mortality in a heterogeneous population of 10,025 cardiac surgery recipients. Similarly, in an analysis of 3500 patients, Karkouti and colleagues 18 demonstrated a 2-fold increase in the risk-adjusted odds of composite mortality, stroke, and renal injury in patients with preoperative anemia. An international analysis of more than 5000 patients corroborated these findings in a multi-institution (70 centers) cohort of patients. 19 In addition, the strong correlation between preoperative Hct level and the likelihood of postoperative PRBC transfusion in the present study is consistent with the primary results of former analyses. 17 The results of the present study extend those of former reports, and also address several limitations of previous analyses, including the risk-adjusted hierarchical modeling of preoperative Hct as a continuous function to better understand the relationship between declining Hct level and perioperative mortality and morbidity. These results also provide an analysis of primary, isolated CABG operations alone to avoid the inherent confounding that is often difficult to adjust for in heterogeneous patient populations. Although the impact of intraoperative anemia was not specifically examined in this analysis, previous large cohort studies have demonstrated that nadir Hct levels during cardiopulmonary bypass significantly impact postoperative mortality.
21-23
The main results of this study demonstrate that PRBC transfusion has a greater effect than preoperative Hct on the likelihood of postoperative mortality, stroke, and renal failure after adjustment for the confounding influence of baseline patient risk profile, differences at the hospital level, and year of operation. These conclusions are based on the significantly higher strength of association (as determined by P values and model AUC) estimated for the effect of PRBC transfusion (compared with preoperative Hct) with each outcome. Although several previous analyses have demonstrated the adverse impact of either anemia or blood transfusions alone on mortality and morbidity, 5, 8, [24] [25] [26] our study design is unique in that it more directly addresses the question of which factor (anemia vs transfusion) contributes more to poor patient outcomes. This methodology and results are important, demonstrating that although anemia and PRBC transfusion are often clinically related events, the estimated negative impact of PRBC transfusion is greater, and efforts to avoid transfusion when clinically feasible should be considered.
The present results have significant clinical implications related to the perioperative management of patients undergoing surgical myocardial revascularization. A fundamental limitation of any analysis of blood product utilization after cardiac surgery is the criticism that the number of blood product transfusions likely represents a surrogate for sicker patient populations compared with patients not requiring blood products. This factor has been addressed in many former risk-adjusted and propensity score cohort matched analyses. 5, 8, [24] [25] [26] While a legitimate concern, results of these analyses, as well as the present, have consistently identified transfusion as an independent risk factor for mortality. As a result, our demonstration of a highly significant and strong association between preoperative Hct and the likelihood of PRBC transfusion further supports the critical role of proper preoperative planning and correction of preoperative anemia when possible to avoid the untoward effects of PRBC transfusion following cardiac surgery. Thus, these results further corroborate blood conservation efforts and guidelines advanced by the STS and Society of Cardiovascular Anesthesiologists, including (1) efforts designed to increase preoperative blood volume (eg, erythropoietin, autologous preoperative blood donation), (2) intraoperative blood conservation and cell-saving devices, (3) interventions to avoid operative stress, (4) implementation of institution-specific transfusion algorithms, (5) use of multimodal blood conservation techniques, and (6) use of miniaturized cardiopulmonary bypass circuits and modified ultrafiltration to maximize intraoperative and postoperative Hct levels. 27, 28 In addition, the results of this study further highlight the importance of focusing on blood conservation efforts, given that previous reports have demonstrated the significantly increased economic burden of blood product transfusion on healthcare costs after cardiac surgery. 8, 25 This study has some noteworthy limitations. The retrospective study design introduces inherent selection bias. The results reported here reflect observed associations between modeled factors and outcomes, but do not demonstrate direct cause-and-effect relationships. An additional limitation concerns the methods used to measure and report preoperative Hct. Measurements of a single, preoperative blood Hct level as opposed to alternative measurements (eg, average Hct) may overestimate or underestimate the relationships between preoperative Hct or degree of anemia and measured outcomes. Furthermore, the impact of transfusions performed in the preoperative setting in an effort to correct anemia and optimize preoperative status could not be determined or analyzed. The deidentified nature of a large data registry is inherently limited to the analysis of predefined variables, variable definitions, and variable granularity. As a result, it was not possible to directly analyze the impact of anemia or transfusion on the likelihood of transfusion-related acute lung injury, infectious complications, or transfusion reactions. Timing of blood transfusion was not captured in the VCSQI data registry, a limitation of currently captured data in the STS national database as well. Although outside the scope of this analysis, additional investigation of the impact of other blood products on outcomes would be beneficial. The study is constrained by a lack of long-term reports of outcomes. Unrecognized miscoding of data must also be considered in any secondary analysis of a data registry. Finally, risk adjustment using the STS predicted risk of mortality might not completely account for association of postoperative complications and transfusion requirements. Despite these limitations, this analysis provides a robust analysis of the largest multiinstitution cohort of CABG recipients reported to date with the specific aim of determining the relative clinical impact of preoperative Hct level versus PRBC transfusion. 
CONCLUSIONS
The primary results of this multi-institution analysis of CABG outcomes demonstrate that PRBC transfusion is more strongly associated with risk-adjusted morbidity and mortality compared with preoperative Hct level alone. Preoperative anemia independently increases the risk of postoperative morbidity and mortality, but more strongly increases the likelihood of postoperative PRBC transfusion. Therefore, our data support efforts to reduce unnecessary PRBC transfusions. Our results suggest that preoperative Hct levels should be considered for inclusion in the STS risk calculators. Finally, efforts to optimize preoperative Hct to avoid anemia should be investigated as a potentially modifiable risk factor for morbidity and mortality.
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